abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapelocationmap-pinminusnewsorganisationotheroverviewpluspreviewprofilerefreshnewssearchsecurityPathtagticktooltiptwitteruniversalityweb

Gavi steps up child vaccine funding programme

The Global Alliance for Vaccines and Immunisation (Gavi) said...it will provide more funding for developing countries to introduce vaccines against severe diarrhoea and pneumonia, two leading causes of child deaths. Gavi, a public-private partnership to help the world's poorest countries obtain vital vaccines and reduce child mortality, described the rollout of rotavirus and pneumococcal vaccines as its biggest commitment of funds to date...The vaccines for pneumonia will come from GlaxoSmithKline (GSK) and Wyeth [part of Pfizer] and the target price for them will be $3.50, 90% less than when sold in the west. The vaccines for diarrhoea will be provided by GSK and Merck, again at a greatly reduced price of $5.